Articles
These three clinical papers have been chosen by our experts to give you the opportunity to explore these topics in greater depth. They include an overview of the treatment of Dravet syndrome with antiepileptic drugs and the ketogenic diet; one of the key phase 3 trials of fenfluramine in patients taking stiripentol; and a real-world study of add-on therapy with fenfluramine.
Infographics
This infographic for provides an overview of the efficacy and tolerability of fenfluramine and cannabidiol and outlines potential future treatments.
KOL Commentaries
In this video, Dr Nicola Specchio, Professor Renzo Guerrini and Professor Rima Nabbout discuss their experience of treating patients with Dravet syndrome with fenfluramine and cannabidiol in clinical trials and in the real-world setting, and review their place in management.
